Back to Search Start Over

One Year Overview and Follow-Up in a Post-COVID Consultation of Critically Ill Patients.

Authors :
González J
Zuil M
Benítez ID
de Gonzalo-Calvo D
Aguilar M
Santisteve S
Vaca R
Minguez O
Seck F
Torres G
de Batlle J
Gómez S
Barril S
Moncusí-Moix A
Monge A
Gort-Paniello C
Ferrer R
Ceccato A
Fernández L
Motos A
Riera J
Menéndez R
Garcia-Gasulla D
Peñuelas O
Labarca G
Caballero J
Barberà C
Torres A
Barbé F
Source :
Frontiers in medicine [Front Med (Lausanne)] 2022 Jul 14; Vol. 9, pp. 897990. Date of Electronic Publication: 2022 Jul 14 (Print Publication: 2022).
Publication Year :
2022

Abstract

The long-term clinical management and evolution of a cohort of critical COVID-19 survivors have not been described in detail. We report a prospective observational study of COVID-19 patients admitted to the ICU between March and August 2020. The follow-up in a post-COVID consultation comprised symptoms, pulmonary function tests, the 6-minute walking test (6MWT), and chest computed tomography (CT). Additionally, questionnaires to evaluate the prevalence of post-COVID-19 syndrome were administered at 1 year. A total of 181 patients were admitted to the ICU during the study period. They were middle-aged (median [IQR] of 61 [52;67]) and male (66.9%), with a median ICU stay of 9 (5-24.2) days. 20% died in the hospital, and 39 were not able to be included. A cohort of 105 patients initiated the follow-up. At 1 year, 32.2% persisted with respiratory alterations and needed to continue the follow-up. Ten percent still had moderate/severe lung diffusion (DLCO) involvement (<60%), and 53.7% had a fibrotic pattern on CT. Moreover, patients had a mean (SD) number of symptoms of 5.7 ± 4.6, and 61.3% met the criteria for post-COVID syndrome at 1 year. During the follow-up, 46 patients were discharged, and 16 were transferred to other consultations. Other conditions, such as emphysema (21.6%), COPD (8.2%), severe neurocognitive disorders (4.1%), and lung cancer (1%) were identified. A high use of health care resources is observed in the first year. In conclusion, one-third of critically ill COVID-19 patients need to continue follow-up beyond 1 year, due to abnormalities on DLCO, chest CT, or persistent symptoms.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2022 González, Zuil, Benítez, de Gonzalo-Calvo, Aguilar, Santisteve, Vaca, Minguez, Seck, Torres, de Batlle, Gómez, Barril, Moncusí-Moix, Monge, Gort-Paniello, Ferrer, Ceccato, Fernández, Motos, Riera, Menéndez, Garcia-Gasulla, Peñuelas, Labarca, Caballero, Barberà, Torres and Barbé.)

Details

Language :
English
ISSN :
2296-858X
Volume :
9
Database :
MEDLINE
Journal :
Frontiers in medicine
Publication Type :
Academic Journal
Accession number :
35911414
Full Text :
https://doi.org/10.3389/fmed.2022.897990